Macomics
  • About us
    • About us
    • Team
    • Board
    • Scientific Advisors
    • Investors
  • Science
    • Science
    • Publications
  • Pipeline
  • Partnering
  • News & Events
    • News
    • Events
  • Working Here
  • Contact us

Month: July 2020

Macomics secures £3.2 million seed funding

Posted on 14 July 20209 May 2025 by edgover

Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, launches today with a £3.2 million seed financing round led by transatlantic VC Epidarex Capital, with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also investing.

Posted in Uncategorized

Recent Posts

  • Macomics Team Scores Gold and Raises Over £600 in its Hyper-Triathlon Challenge in aid of Founder Prof. Jeffrey Pollard’s Memorial Fund
  • Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development
  • Macomics Announces Appointment of Simon Dew as New Chief Business Officer
  • Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration
  • Macomics Unveils its Lead First-in-Class Anti-Pan-LILR Monoclonal Antibody Programme with Positive Pre-clinical Data Presented at AACR 2024

Recent Comments

No comments to show.

Archives

  • August 2024
  • June 2024
  • May 2024
  • April 2024
  • October 2023
  • September 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • May 2022
  • January 2022
  • November 2021
  • October 2021
  • July 2021
  • May 2021
  • March 2021
  • July 2020

Categories

  • Uncategorized
TERMS OF USE
PRIVACY POLICY & COOKIES
© COPYRIGHT 2025 MACOMICS
 Follow us on LinkedIn